понедельник, 25 января 2016 г.

GSK, Astra, J&J link with universities in new drug research fund

GSK, Astra, J&J link with universities in new drug research fund


GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 million pounds fund backing early drug research. The Apollo Therapeutics Fund, which aims to improve the speed and potential of university research being translated into new medicines, is a further example of a trend by Big Pharma to tap into academic science in the hunt for treatments.



from Biotech News